In experimental models of human pulmonary carcinoid and SCLC cells, the inhibition of the PI3K/Akt pathway by LY294002 and Tricribine, respectively, significantly reduced cellular growth and neuroendocrine marker expression in vitro and increased apoptosis and sensitivity to chemotherapeutic treatments (28,36). This evidence concerns the gene PIK3CA and small cell lung carcinoma.